Functional Fluidics' featured Sickle Cell Disease articles & news stories: www.functionalfluidics.com
“Tricuspid regurgitation velocity and other biomarkers of mortality in children, adolescents and young adults with sickle cell disease in the United States: The PUSH study”
"In the US, mortality in sickle cell disease (SCD) increases after age 18-20 years. Biomarkers of mortality risk can identify patients who need intensive follow-up and early or novel interventions" : https://pubmed.ncbi.nlm.nih.gov/32243618
